Tag

Cancer
26
Feb

Breast cancer incidence rising among women under 50

Breast cancer incidence is rising among U.S. women under 50, according to new research published in JAMA Network Open [1].Read More

Read More

27
Oct

Pretargeted radioimmunotherapy shows early promise in treating aggressive ovarian cancer

A recently developed pretargeted radioimmunotherapy (PRIT) system has displayed potential in treating advanced epithelial ovarian cancer with limited side effects. This therapy, known as anti-HER2 225Ac-PRIT, specifically targets a protein commonly found

Read More

11
Oct

‘Immediate attention’ needed to address cancer diagnosis deficits stemming from pandemic

“Immediate attention” is needed to address cancer diagnosis deficits stemming from the COVID-19 health crisis, researchers charged in a new analysis published Tuesday in JAMA Network Open [1]

Read More

27
Sep

Experts advocate for more intensive head-and-neck cancer follow-up using FDG-PET/CT

Experts are touting the benefits of an intensive follow-up regimen for head and neck squamous cell carcinoma (HNSCC) using PET/CT.

Read More

29
Nov

Cancer death rates drop again

Cancer death rates have dropped again among men, women, children and adolescents and young adults across demographics. The latest data comes from the ‘Annual Report to the Nation on the Status of Cancer’, which recently determined cancer death rates have declined from 2015 to 2019.

Read More

27
Aug

New technology may help detect lung cancer earlier at the cellular level

Lung cancer is the leading cause of cancer death worldwideTrusted Source and the third most commonTrusted Source cancer type in the United States. The disease is often treatable when diagnosed in its early stages. So, experts are constantly working on new ways to detect lung cancer as early as possible so that people can receive prompt treatment.

Read More

29
Jun

Bridging the gap between prostate radiology and pathology through machine learning

Prostate cancer remains the second deadliest cancer for men despite clinical advancements. Currently, Magnetic Resonance Imaging (MRI) is considered the most sensitive non-invasive imaging modality that enables visualisation, detection and localisation of prostate cancer, and is increasingly used to guide targeted biopsies for prostate cancer diagnosis. However, its utility remains limited due to high rates...

Read More

23
May

No more biopsy? Handheld device could painlessly identify skin cancers

Source: A new device uses millimeter-wave imaging (the same technology used in airport security scanners) to scan a patient’s skin to detect if they have skin cancer. Millimeter-wave rays harmlessly penetrate about 2mm into human skin, so the team’s imaging technology provides a clear 3D map of scanned skin lesions.

Read More

09
May

RANZCR Submission to the Australian Cancer Plan 2023 – 2033

Source: RANZCR has provided this submission to Cancer Australia’s consultation as part of the development of the Australian Cancer Plan 2023–2033. There were 52 recommendations made addressing the following topics: cancer screening, technologies and treatments, digital cancer care strategy, national cancer guidelines, patient access, funding and cancer research.

Read More

18
Apr

Artificial sweeteners linked with a 13% higher risk of cancer

Source: A new observational study has found an association between the consumption of artificial sweeteners, such as aspartame and acesulfame-K, to cancer. The worldwide artificial sweetener market is estimated at $22.2 billion and rising, a nearly three-billion-dollar increase in the last 2 years alone.

Read More

1 2 3 4

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. Gloreen G at GCG has vast experience and understanding of the specialist medical and diagnostic imaging market. This gives GCG the ability to ensure that you receive the very best salary and incentives package, including leave entitlements, days off, paid conferences and radiology expenses.